Korro Bio, Inc. (KRRO) Ownership

NASDAQ: KRROTop holders, insider trades and short interest.

KRRO ownership summary

as of October 18, 2026
Institutions
105.2%
of shares outstanding
Insiders
0.89%
of shares outstanding
Shares outstanding
14.7M
Float
10.6M
shares available to trade
Short interest
12.74%
1.7M shares short
Days to cover
8.66
short interest up 7.9% vs prior month
  • Institutions 105.22%
  • Insiders 0.89%

KRRO top institutional holders

20 largest
Korro Bio, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Lynx1 Capital Management, LP10.45%1.5M$13.1M—June 30, 2026
2Nantahala Capital Management, LLC8.96%1.3M$11.2M+660,036 (+100.0%)June 30, 2026
3NEA Management Company, LLC8.81%1.3M$11.0M—June 30, 2026
4VR Adviser, LLC6.86%1.0M$8.6M—June 30, 2026
5Atlas Venture Life Science Advisors, LLC6.54%963K$8.2M−174,265 (−15.3%)June 30, 2026
6Balyasny Asset Management LLC6.46%952K$8.1M−88,271 (−8.5%)June 30, 2026
7BlackRock Inc5.55%818K$6.9M+357,615 (+77.7%)June 30, 2026
8Affinity Asset Advisors, LLC4.80%707K$6.0M—June 30, 2026
9Adage Capital Partners Gp LLC3.67%541K$4.6M+312,568 (+136.9%)June 30, 2026
10ADAR1 Capital Management LLC3.67%540K$4.6M—June 30, 2026
11Vanguard Capital Management, LLC3.09%455K$3.9M+143,865 (+46.3%)June 30, 2026
12Driehaus Capital Management LLC3.06%450K$3.8M—June 30, 2026
13TCG Crossover Management, LLC2.83%416K$3.5M—June 30, 2026
14Kalehua Capital Management LLC2.75%405K$3.4M+295,664 (+270.3%)June 30, 2026
15Siren, L.L.C.2.36%348K$3.0M—June 30, 2026
16AQR Capital Management LLC2.03%299K$2.5M+31,219 (+11.7%)June 30, 2026
17Geode Capital Management, LLC2.02%297K$2.5M+123,227 (+71.0%)June 30, 2026
1872 Investment Holdings, LLC1.88%277K$2.4M—June 30, 2026
19State Street Corp1.58%233K$2.0M+92,246 (+65.7%)June 30, 2026
20Vanguard Portfolio Management, LLC1.52%224K$1.9M+74,992 (+50.5%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 2.1M shares and 2 cut 263K.

KRRO top mutual fund and ETF holders

20 largest
Korro Bio, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.11%311K$2.6M—August 31, 2026
2iShares Russell 2000 ETF1.96%289K$2.4M−3,328 (−1.1%)September 30, 2026
3Fidelity Small Cap Index0.83%122K$1.0M+708 (+0.6%)July 31, 2026
4Vanguard Strategic Small-Cap Equity Inv0.72%106K$903,294+18,055 (+20.4%)June 30, 2026
5iShares Russell 2000 Value ETF0.56%83K$704,551+126 (+0.2%)September 30, 2026
6F/m Emerald Life Sciences Innovation ETF0.44%65K$555,603—September 30, 2026
7Vanguard Russell 2000 ETF0.43%64K$543,717+1,320 (+2.1%)August 31, 2026
8Fidelity Extended Market Index0.42%62K$525,455+5,815 (+10.4%)August 31, 2026
9iShares Micro-Cap ETF0.24%35K$299,264−243 (−0.7%)September 30, 2026
10Vanguard Health Care ETF0.19%29K$242,822+120 (+0.4%)August 31, 2026
11Schwab Small Cap Index0.18%27K$228,126—August 31, 2026
12Stt Strt SPDR® Russell2000 US SmCapETF0.16%24K$203,268+1,152 (+5.1%)August 31, 2026
13iShares Russell 2000 Small-Cap Idx Instl0.14%21K$176,821—August 31, 2026
14Fidelity Total Market Index0.14%20K$170,895—August 31, 2026
15Fidelity Series Total Market Index0.12%18K$153,525+1,424 (+8.5%)August 31, 2026
16Avantis US Small Cap Equity ETF0.11%16K$134,057—September 30, 2026
17Nuveen Small Cap Blend Idx R60.10%15K$126,331—August 31, 2026
18Vanguard VIF Small Co Gr0.10%15K$124,124+14,620 (0.0%)June 30, 2026
19Fidelity Small Cap Value Index0.09%13K$108,791—July 31, 2026
20EQ/2000 Managed Volatility IB0.08%12K$104,087—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

KRRO insider transactions

latest 9
Korro Bio, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-03-31Lynx1 Capital Management LpBuy$10.60520$5,512
2026-03-10Anthony A Jr. FlorenceBuy$11.11207,100$2.3M
2026-03-10Edward T MathersBuy$11.11207,100$2.3M
2026-03-10Enterprise Associates 17 NewBuy$11.11207,100$2.3M
2026-03-10Forest BaskettBuy$11.11207,100$2.3M
2026-03-10Mohamad MakhzoumiBuy$11.11207,100$2.3M
2026-03-10Paul Edward WalkerBuy$11.11207,100$2.3M
2026-03-10Rick YangBuy$11.11207,100$2.3M
2026-03-10Scott D SandellBuy$11.11207,100$2.3M

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

KRRO shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns KRRO

Institutional investors own 105.2% of Korro Bio's shares and insiders 0.89%. The largest holder is Lynx1 Capital Management, LP with 10.45% of the shares (1.5M), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 2 reduced their stake in the latest filings. Short interest is 12.74% of the float, or 8.66 days of average trading volume. The share count rose 1,423.0% since 2019.

Related: KRRO analyst forecast, KRRO key metrics. See the KRRO stock overview for the latest quote and news.

KRRO ownership FAQ

Who owns the most Korro Bio stock?

The largest shareholders of Korro Bio are Lynx1 Capital Management, LP (10.45%), Nantahala Capital Management, LLC (8.96%), NEA Management Company, LLC (8.81%), VR Adviser, LLC (6.86%), Atlas Venture Life Science Advisors, LLC (6.54%).

What percentage of Korro Bio is owned by institutions?

Institutions hold 105.2% of Korro Bio's shares outstanding; insiders hold 0.89%.

Which funds own Korro Bio?

The largest fund holders of Korro Bio are Vanguard MStar Total Stk Mkt Idx Invest (2.11%), iShares Russell 2000 ETF (1.96%), Fidelity Small Cap Index (0.83%), Vanguard Strategic Small-Cap Equity Inv (0.72%), iShares Russell 2000 Value ETF (0.56%).

What is Korro Bio's short interest?

1.7M shares of Korro Bio were sold short, 12.74% of the float; at the average daily volume it would take 8.66 days to cover.

Are insiders buying or selling Korro Bio?

Of the latest 9 reported insider transactions in Korro Bio (since March 10, 2026), 9 were purchases and 0 were sales.

How many shares of Korro Bio are outstanding?

Korro Bio has 14.7M shares outstanding, of which 10.6M are in the public float.

Biotechnology: ownership